VAS2870 and VAS3947 attenuate platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC

Medicine and Dentistry

• 15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid 16%
• 2 (2 Chlorophenyl) 4 [3 (Dimethylamino)phenyl] 5 Methyl 1h pyrazolo[4,3 C]pyridine 3,6(2h,5h) Dione 16%
• Antiplatelet 33%
• Blood Clotting 100%
• Blood Stasis 16%
• Calcium Mobilization 16%
• Cardiovascular Disease 16%
• Oxidoreductase Inhibitor 16%
• p38 Mitogen-Activated Protein Kinase 16%
• Pathological Process 16%
• Platelet 16%
• Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 100%
• Therapeutic Agent 16%
• Thrombin 33%
• Thrombocyte Activation 100%
• Thrombocyte Aggregation 66%

Pharmacology, Toxicology and Pharmaceutical Science

• 15 Hydroxy 11alpha,9alpha Epoxymethanoprosta 5,13 Dienoic Acid 16%
• 2 (2 Chlorophenyl) 4 [3 (Dimethylamino)phenyl] 5 Methyl 1h pyrazolo[4,3 C]pyridine 3,6(2h,5h) Dione 16%
• Antiplatelet 33%
• Blood Stasis 16%
• Cardiovascular Disease 16%
• Inflammation 16%
• Mouse 16%
• Oxidoreductase Inhibitor 16%
• Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 100%
• Thrombin 33%
• Thrombus 100%